scholarly journals Variable phenotype of familial adenomatous polyposis in pedigrees with 3′ mutation in the APC gene

Gut ◽  
1998 ◽  
Vol 43 (4) ◽  
pp. 548-552 ◽  
Author(s):  
J D Brensinger ◽  
S J Laken ◽  
M C Luce ◽  
S M Powell ◽  
G H Vance ◽  
...  

Background—Germline mutation in the adenomatous polyposis coli (APC) gene on chromosome 5 causes familial adenomatous polyposis. “Attenuated” phenotype has been reported with mutation in the 5′ end of the gene (5′ to codon 158), but genotype-phenotype relations at the 3′ end (3′ to codon 1596) have not been described fully.Aims—To describe and compare colorectal and extracolonic phenotypes in a case series of families with mutation in the 3′ end of the APC gene.Methods—Thirty one at risk or affected members from four families with a mutation in the APC gene located at codon 1979 or 2644 were evaluated.Results—Variable intrapedigree colorectal phenotype was observed: some members at older age had oligopolyposis (fewer than one hundred colorectal adenomas) whereas other members had classic polyposis at young age. Colorectal cancer was diagnosed at older mean age (50 (7) years) in the four families than in classic FAP pedigrees (39 (14) years). Extracolonic lesions characteristic of FAP occurred with 3′ APC mutations, but variability in intrapedigree and interpedigree extracolonic phenotype and dissociation of severity of extracolonic manifestations from number of colorectal polyps was noted.Conclusions—Families with 3′ mutations of the APC gene exhibit variable intrapedigree phenotype similar to the heterogeneity noted in families with proximal 5′ mutations. Genotyping of FAP and oligopolyposis pedigrees can guide appropriate surveillance of the upper and lower gastrointestinal tract in affected members.

1998 ◽  
Vol 114 ◽  
pp. A569
Author(s):  
JD Brensinger ◽  
SJ Laken ◽  
MC Luce ◽  
SM Powell ◽  
GH Vance ◽  
...  

2018 ◽  
Vol 6 (6) ◽  
pp. 1031-1040 ◽  
Author(s):  
Farzaneh Pouya ◽  
Afsaneh Mojtabanezhad Shariatpanahi ◽  
Kamran Ghaffarzadegan ◽  
Seyed Abbas Tabatabaee Yazdi ◽  
Hamed Golmohammadzadeh ◽  
...  

1994 ◽  
Vol 4 (4) ◽  
pp. 253-256 ◽  
Author(s):  
Bharati Bapat ◽  
Terri Berk ◽  
Angela Mitri ◽  
Zane Cohen ◽  
Steven Gallinger ◽  
...  

2000 ◽  
Vol 18 (9) ◽  
pp. 1967-1979 ◽  
Author(s):  
Kathleen Heppner Goss ◽  
Joanna Groden

ABSTRACT: The adenomatous polyposis coli (APC) gene was first identified as the gene mutated in an inherited syndrome of colon cancer predisposition known as familial adenomatous polyposis coli (FAP). Mutation of APC is also found in 80% of all colorectal adenomas and carcinomas and is one of the earliest mutations in colon cancer progression. Similar to other tumor suppressor genes, both APC alleles are inactivated by mutation in colon tumors, resulting in the loss of full-length protein in tumor cells. The functional significance of altering APC is the dysregulation of several physiologic processes that govern colonic epithelial cell homeostasis, which include cell cycle progression, migration, differentiation, and apoptosis. Roles for APC in some of these processes are in large part attributable to its ability to regulate cytosolic levels of the signaling molecule beta-catenin and to affect the transcriptional profile in cells. This article summarizes numerous genetic, biochemical, and cell biologic studies on the mechanisms of APC-mediated tumor suppression. Mouse models of FAP, in which the APC gene has been genetically inactivated, have been particularly useful in testing therapeutic and chemopreventive strategies. These data have significant implications for colorectal cancer treatment approaches as well as for understanding other disease genes and cancers of other tissue types.


2017 ◽  
Vol 1 (Special Issue-Supplement) ◽  
pp. 252-252
Author(s):  
Snigdha Majumder ◽  
Rakshit Shah ◽  
Jisha Elias ◽  
Yogesh Mistry ◽  
Coral Karunakaran ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document